To compare the effects of long-term treatment with (ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) or another (ultra-)long-acting insulin analogue in people with type 1 diabetes mellitus.
This is a protocol.
To compare the effects of long-term treatment with (ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) or another (ultra-)long-acting insulin analogue in people with type 1 diabetes mellitus.
This is a protocol.